No BigWilly, I am well aware that companies with revenue can go into receivership. What I am pointing out is that companies with record revenue and increasing revenue are unlikely to head into receivership. I am pointing out that the risk/reward ratio for this company is now very low. I also realise that there are a lot of disgruntled share holders who like to post here and vet their animosity. The CEO of this company may have little regard for his shareholders but things change, and profitability will be reflected in a higher share price.
- Forums
- ASX - By Stock
- CTV
- EN1 Renaissance
EN1 Renaissance, page-22
-
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CTV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online